Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-23-002217
Accepted
2023-07-31 00:15:07
Documents
1
Effectiveness Date
2023-07-28
Registration Form
S-1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 597
  Complete submission text file 9999999995-23-002217.txt   1714
Mailing Address 822 A1A NORTH SUITE 300 PONTE VEDRA FL 32082
Business Address 822 A1A NORTH SUITE 300 PONTE VEDRA FL 32082 904-300-0701
Cadrenal Therapeutics, Inc. (Filer) CIK: 0001937993 (see all company filings)

EIN.: 880860746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-273384 | Film No.: 231124908
SIC: 2834 Pharmaceutical Preparations